πŸ‡ΊπŸ‡Έ FDA

Intelligence Platform

Patents

Browse 1,315 pharma-relevant patents (US and EP, A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.

29,054 patents indexed
patent

US 8188076

Compositions, synthesis, and methods of utilizing arylpiperazine derivatives

REVIVA PHARMACEUTICALS, INC. Β· Granted Tue May 29 2012 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 24 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8183338

Sterically hindered poly(ethylene glycol) alkanoic acids and derivatives thereof

Nektar Therapeutics Β· Granted Tue May 22 2012 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 17 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8182801

Method for preparing water-soluble polymer derivatives bearing a terminal carboxylic acid

Nektar Therapeutics Β· Granted Tue May 22 2012 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 17 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8178679

Derivatives of 4-(2-amino-1-hydroxyethyl)phenol as agonists of the Ξ²2 adrenergic receptors

Almirall, S.A. Β· Granted Tue May 15 2012 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 10 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8168751

Interferon alpha mutant and its polyethylene glycol derivative

Beijing Tri-Prime Genetic Engineering Co., Ltd Β· Granted Tue May 01 2012 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 26 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8163707

4β€²-allene-substituted nucleoside derivatives

Enanta Pharmaceuticals, Inc. Β· Granted Tue Apr 24 2012 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 19 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8158754

Multiple modified derivatives of gelatin and crosslinked material thereof

BIOREGEN BIOMEDICAL (CHANGZHOU) CO., LTD. Β· Granted Tue Apr 17 2012 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 12 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8153636

Pyridyl derivatives and their use as therapeutic agents

Xenon Pharmaceuticals Inc. Β· Granted Tue Apr 10 2012 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 05 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8153609

Purine nucleotide derivatives

Lauras AS Β· Granted Tue Apr 10 2012 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 05 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8153686

Amino- and amido-aminotetralin derivatives and related compounds as mu opioid receptor ant

Theravance, Inc. Β· Granted Tue Apr 10 2012 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 05 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8148378

Pyridazine derivatives and their use as inhibitors of stearoyl-CoA desaturase-1 activity i

Xenon Pharmaceuticals Inc. Β· Granted Tue Apr 03 2012 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Mar 29 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8143297

Heterocyclic derivatives as modulators of ion channels

Vertex Pharmaceuticals Incorporated Β· Granted Tue Mar 27 2012 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Mar 22 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8129433

Enterically coated cysteamine, cystamine and derivatives thereof

The Regents of the University of California Β· Granted Tue Mar 06 2012 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Mar 01 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8129405

Quinuclidine derivatives and medicinal compositions containing the same

Almirall Prodesfarma S.A. Β· Granted Tue Mar 06 2012 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Mar 01 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8129546

Derivatives for modulation of ion channels

Vertex Pharmaceuticals Incorporated Β· Granted Tue Mar 06 2012 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Mar 01 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8119769

Complement depletion using recombinant human C-3 derivatives

PLS-Design GmbH Β· Granted Tue Feb 21 2012 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Feb 16 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8119779

Phosphoramidate derivatives

University College Cardiff Consultants Limited Β· Granted Tue Feb 21 2012 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Feb 16 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8106232

3-carboxypropyl-aminotetralin derivatives and related compounds as mu opioid receptor anta

Theravance, Inc. Β· Granted Tue Jan 31 2012 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jan 26 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8101575

Glycopeptide phosphonate derivatives

Theravance, Inc. Β· Granted Tue Jan 24 2012 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jan 19 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8101643

Benzimidazole derivatives

Enanta Pharmaceuticals, Inc. Β· Granted Tue Jan 24 2012 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jan 19 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8101637

Alkynyl derivatives as modulators of metatropic glutamate receptors

Addex Pharma, S.A. Β· Granted Tue Jan 24 2012 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jan 19 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8097610

Derivative having PPAR agonistic activity

Institute of Medicinal Molecular Design, Inc. Β· Granted Tue Jan 17 2012 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jan 12 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8097630

Pinane-substituted pyrimidinediamine derivatives useful as Axl inhibitors

Rigel Pharmaceuticals, Inc. Β· Granted Tue Jan 17 2012 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jan 12 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8097636

Heterocyclic derivatives as modulators of ion channels

Vertex Pharmaceuticals Incorporated Β· Granted Tue Jan 17 2012 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jan 12 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted